< 生产厂家价格 >

(S)-(-)-α-甲基苄基异氰酸酯

(S)-(-)-α-甲基苄基异氰酸酯名称

[ CAS 号 ]:
14649-03-7

[ 中文名 ]:
(S)-(-)-1-苯乙基异氰酸酯

[ 英文名 ]:
(1-Isocyanatoethyl)benzene

[中文别名 ]:

[英文别名 ]:

Benzene, (1-isocyanatoethyl)-
(S)-(-)-alpha-Methylbenzyl isocyanate
(S)-(-)-1-Phenylethyl isocyanate
(S)-(−)-1-Phenylethyl isocyanate
Isocyanic Acid (S)-(-)-1-Phenylethyl Ester
Isocyanic Acid (S)-(-)-α-Methylbenzyl Ester
(S)-(-)-α-Methylbenzyl isocyanate
Benzene, (1-isocyanatoethyl)-, (S)-
(1-Isocyanatoethyl)benzene
[(1S)-1-Isocyanatoethyl]benzene

(S)-(-)-α-甲基苄基异氰酸酯物理化学性质

[ 密度 ]:
1.0±0.1 g/cm3

[ 沸点 ]:
204.1±19.0 °C at 760 mmHg

[ 分子式 ]:
C₉H₉NO

[ 分子量 ]:
147.174

[ 闪点 ]:
65.6±0.0 °C

[ 精确质量 ]:
147.068420

[ PSA ]:
29.43000

[ LogP ]:
2.95

[ 外观性状 ]:
略黄色

[ 蒸汽压 ]:
0.3±0.4 mmHg at 25°C

[ 折射率 ]:
1.515

[ 储存条件 ]:
0-10°C;存放于惰性气体之中;避免湿气 (分解),加热

(S)-(-)-α-甲基苄基异氰酸酯MSDS

(S)-(-)-α-甲基苄基异氰酸酯安全信息

[ 符号 ]:

GHS06, GHS08

[ 信号词 ]:
Danger

[ 危害声明 ]:
H315-H319-H330-H334-H335

[ 警示性声明 ]:
P260-P284-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ 危害码 (欧洲) ]:
Xn:Harmful;

[ 风险声明 (欧洲) ]:
R36/37/38;R42

[ 安全声明 (欧洲) ]:
S23-S26-S36

[ 危险品运输编码 ]:
UN 2206

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1

[ 海关编码 ]:
2929109000

(S)-(-)-α-甲基苄基异氰酸酯合成路线

(S)-(-)-α-甲基苄基异氰酸酯上下游产品

(S)-(-)-α-甲基苄基异氰酸酯上游产品

(S)-(-)-α-甲基苄基异氰酸酯下游产品

(S)-(-)-α-甲基苄基异氰酸酯海关

[ 海关编码 ]: 2929109000

[ 中文概述 ]:
2929109000. 其他异氰酸酯. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2929109000. other isocyanates. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

(S)-(-)-α-甲基苄基异氰酸酯文献

High-performance liquid chromatographic determination of the enantiomers of beta-adrenoceptor blocking agents in biological fluids. II. Studies with atenolol.

J. Chromatogr. A. 489(2) , 438-45, (1989)

Derivatization of (+/-)-5-[(2-methylphenoxy)methyl]-2-amino-2-oxazoline, an imidazoline binding sites ligand, with (+)-(R)-alpha-methylbenzyl isocyanate for drug monitoring purposes.

J. Enzyme Inhib. Med. Chem. 17(6) , 375-9, (2002)

The derivatization of racemic 5-[(2-methylphenoxy)methyl]-2-amino-2-oxazoline, developed as an imidazoline binding sites ligand, with (+)-(R)-alpha-methylbenzyl isocyanate was performed in chloroform....

更多文献